Hepatotoxicity associated with the administration of voriconazole (VRCZ) is a treatment-related adverse event that necessitates discontinuation of administration in some cases. This study is aimed at investigating the clinical features of VRCZ-induced hepatotoxicity in pediatric patients, including the status of hepatic damage before the administration of VRCZ.
VRCZ maintenance dose (mg/kg/time) Over attachment dose (no 〔％〕 ) 1 (9.1％) 0 (0％) 1 Table 4 Clinical risk factors associated with occurrence of voriconazole-induced hepatotoxicity and severe hepatotoxicity 
